Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mozambique
Mozambique: Pneumococcal conjugate second or third-dose vaccines (PCVc) was 70.0% in 2025. ◆ Volatile
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mozambique, 2008–2025
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for pneumococcal conjugate second or third-dose vaccines (pcvc) in Mozambique is 70.0%, measured in 2025.
Compared with earlier readings it is down 12.5% over ten years.
Over the whole period, pneumococcal conjugate second or third-dose vaccines (pcvc) in Mozambique peaked at 80.0% in 2015 and was at its lowest, 0.0%, in 2008.
Mozambique ranks 134th of 194 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mozambique, year by year
| Year | Value | Change |
|---|---|---|
| 2008 | 0.0% | — |
| 2009 | 0.0% | — |
| 2010 | 0.0% | — |
| 2011 | 0.0% | — |
| 2012 | 0.0% | — |
| 2013 | 45.0% | — |
| 2014 | 76.0% | +68.9% |
| 2015 | 80.0% | +5.3% |
| 2016 | 80.0% | +0.0% |
| 2017 | 80.0% | +0.0% |
| 2018 | 80.0% | +0.0% |
| 2019 | 80.0% | +0.0% |
| 2020 | 68.0% | -15.0% |
| 2021 | 56.0% | -17.6% |
| 2022 | 55.0% | -1.8% |
| 2023 | 70.0% | +27.3% |
| 2024 | 70.0% | +0.0% |
| 2025 | 70.0% | +0.0% |
Mozambique compared with similar countries
- Mozambique's 70.0% is below the median for low income countries, which is 80.0%, 88% of the median. (25 countries reporting)
- Mozambique's 70.0% is below the median for Sub-Saharan Africa, which is 82.5%, 85% of the median. (48 countries reporting)
Biggest year-on-year movements
Years where Pneumococcal conjugate second or third-dose vaccines (PCVc) in Mozambique changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.
| Year | Change | From | To |
|---|---|---|---|
| 2014 | +68.9% | 45.0% | 76.0% |
| 2023 | +27.3% | 55.0% | 70.0% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | 2 |
| 2010s | 52.1% | 0.0% | 80.0% | 10 |
| 2020s | 64.8% | 55.0% | 70.0% | 6 |
Countries ranked near Mozambique
More health data for Mozambique
- Un projection of annual infant deaths, annual growth rate -1.85 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 1.16 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 869.7 deaths per 1,000 people (2090)
- Number of infants who die before age 1 18,288 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 139 (2025)
- Population ages 00-04, female, annual growth rate 1.92 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0823 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.92 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is pneumococcal conjugate second or third-dose vaccines (pcvc) in Mozambique?
- Pneumococcal conjugate second or third-dose vaccines (pcvc) in Mozambique was 70.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Mozambique?
- The highest recorded value was 80.0% in 2015.
- What is the lowest pneumococcal conjugate second or third-dose vaccines (pcvc) recorded in Mozambique?
- The lowest recorded value was 0.0% in 2008.
- How does Mozambique rank for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Mozambique ranks 134th out of 194 countries with data for 2025.
- Is pneumococcal conjugate second or third-dose vaccines (pcvc) rising or falling in Mozambique?
- Over the last ten years it is down 12.5%. The long-run trend across the full record is volatile.
- Where does this Mozambique data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 18 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).